Skip to main content
Patient-Reported Outcomes (PROs) from the Phase 2 TRANSCEND FL Study of Lisocabtagene Maraleucel (liso-cel) in Patients (pts) with Relapsed or Refractory Follicular Lymphoma (FL) Cartron, G., Garcia-Sancho, A., Reguera, J., Dahiya, S., Guo, S., Shi, L., Eliason, L., Kumar, J., Farazi, T., Fasan, O., Izutsu, K. AMER SOC HEMATOLOGY. 2023

View details for DOI 10.1182/blood-2023-180175

View details for Web of Science ID 001159306702180